(S)-4-Chloro-2-(3-(3-methyl-1H-indazol-5-yl)-5-(1-phenylethylamino)pyridin-2-yl)phenol

ID: ALA4101681

PubChem CID: 137661021

Max Phase: Preclinical

Molecular Formula: C27H23ClN4O

Molecular Weight: 454.96

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1n[nH]c2ccc(-c3cc(N[C@@H](C)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12

Standard InChI:  InChI=1S/C27H23ClN4O/c1-16(18-6-4-3-5-7-18)30-21-14-23(19-8-10-25-22(12-19)17(2)31-32-25)27(29-15-21)24-13-20(28)9-11-26(24)33/h3-16,30,33H,1-2H3,(H,31,32)/t16-/m0/s1

Standard InChI Key:  UTUIDOAJVKTSNZ-INIZCTEOSA-N

Molfile:  

     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   40.1866  -28.0596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8962  -27.6501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8934  -26.8316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1848  -26.4263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6010  -28.0610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6010  -28.8793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.3044  -29.2908    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.0207  -28.8811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.0209  -28.0597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.3087  -27.6518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.7348  -27.6433    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.4487  -28.0524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.1543  -27.6402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.4528  -28.8696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4785  -27.6506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4793  -26.8337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7015  -26.5831    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.2257  -27.2370    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.7028  -27.9033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4493  -28.6815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.7427  -29.2758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.7424  -30.0964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.4528  -30.5063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.1566  -30.0980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.1575  -29.2747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8953  -29.2866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1885  -28.8742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4801  -29.2801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4773  -30.0981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1888  -30.5087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8943  -30.1004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6019  -30.5092    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.6845  -29.0639    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 15  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4 16  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  2  5  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  1
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 15  1  0
 19 20  1  0
 14 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 14  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
  6 26  1  0
 31 32  1  0
 28 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4101681

    ---

Associated Targets(Human)

FGFR2 Tclin Fibroblast growth factor receptor 2 (3405 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR3 Tclin Fibroblast growth factor receptor 3 (7811 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 454.96Molecular Weight (Monoisotopic): 454.1560AlogP: 7.13#Rotatable Bonds: 5
Polar Surface Area: 73.83Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.55CX Basic pKa: 3.45CX LogP: 5.80CX LogD: 5.57
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.26Np Likeness Score: -1.05

References

1. Zhu W, Chen H, Wang Y, Wang J, Peng X, Chen X, Gao Y, Li C, He Y, Ai J, Geng M, Zheng M, Liu H..  (2017)  Design, Synthesis, and Pharmacological Evaluation of Novel Multisubstituted Pyridin-3-amine Derivatives as Multitargeted Protein Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer.,  60  (14): [PMID:28714692] [10.1021/acs.jmedchem.7b00076]

Source